Literature DB >> 9422526

Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome.

A Bellocq1, M Antoine, A Flahault, C Philippe, B Crestani, J F Bernaudin, C Mayaud, B Milleron, L Baud, J Cadranel.   

Abstract

Tumor infiltrate, predominantly constituted by lymphocytes, may represent an important prognostic factor in bronchioloalveolar carcinoma (BAC), in addition to tumor extension and histological type. In the present study, we determined the presence, the origin, and the prognostic importance of neutrophils that also participate in leukocyte infiltrates of BAC. Neutrophil alveolitis was determined immunohistochemically in both lung biopsies and bronchoalveolar lavage (BAL) fluid samples from 29 patients with histologically proved BAC. The local expression of interleukin (IL)-8 was determined by immunohistochemical and immunoenzymatic techniques. Neutrophil counts were analyzed in relation to the clinical outcome of patients by the Kaplan-Meier method and Cox's univariate and stepwise multivariate models. Lymphocytes and neutrophils dominated the inflammatory cell population in the lower respiratory tract of patients with BAC. Neutrophils were located mainly in the alveolar lumen and seldom in alveolar wall whereas lymphocytes were exclusively present in alveolar wall. A relationship was observed between the number of neutrophils and the level of IL-8 in BAL fluid suggesting the involvement of that chemokine in neutrophil recruitment. The tumor cells were the predominant cells that appeared to express IL-8 by immunolocalization. The presence of increased numbers of neutrophils was significantly associated with a poorer outcome in patients with BAC (P = 0.02). In a multivariate analysis, the neutrophil percentage in BAL fluid was an independent predictor of clinical outcome. The risk of death was increased substantially (rate ratio, 5.2; 95% confidence interval, 1.1 to 24.7) among patients with BAL neutrophil percentage of > or = 39% (median of the distribution) as compared with the others. In BAC, neutrophils accumulate in the alveolar lumen. Elaboration of IL-8 by tumor cells may be responsible for this event, which is associated with a significantly higher risk of death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422526      PMCID: PMC1858104     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

Review 1.  The spectrum and significance of bronchioloalveolar carcinomas.

Authors:  F Clayton
Journal:  Pathol Annu       Date:  1988

2.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

Review 3.  Alveolar carcinoma: a review.

Authors:  C W Edwards
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

4.  Alveolar cell carcinoma.

Authors:  M J Marzano; T Deschler; R A Mintzer
Journal:  Chest       Date:  1984-07       Impact factor: 9.410

5.  Cytologic diagnosis of bronchioloalveolar carcinoma by fine-needle aspiration biopsy.

Authors:  L C Tao; G L Weisbrod; F G Pearson; D E Sanders; E E Donat; L Filipetto
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

6.  Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.

Authors:  F Clayton
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

7.  Bronchoalveolar cell carcinoma of the lung.

Authors:  R J Greco; R M Steiner; S Goldman; H Cotler; A Patchefsky; H E Cohn
Journal:  Ann Thorac Surg       Date:  1986-06       Impact factor: 4.330

8.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

Authors:  D A Arenberg; S L Kunkel; P J Polverini; M Glass; M D Burdick; R M Strieter
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

9.  Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells.

Authors:  T K Lee; R D Horner; J F Silverman; Y H Chen; C Jenny; C W Scarantino
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

10.  In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters.

Authors:  T An; U Sood; T Pietruk; G Cummings; K Hashimoto; J D Crissman
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

View more
  84 in total

1.  The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.

Authors:  M G Luciani; A Stoppacciaro; G Peri; A Mantovani; L P Ruco
Journal:  Mol Pathol       Date:  1998-10

2.  Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis.

Authors:  Haris G Vikis; Andrew E Gelman; Andrew Franklin; Lauren Stein; Amy Rymaszewski; Jihong Zhu; Pengyuan Liu; Jay W Tichelaar; Alexander S Krupnick; Ming You
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

Review 3.  Neutrophils: key mediators of tumour angiogenesis.

Authors:  Simon Tazzyman; Claire E Lewis; Craig Murdoch
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment.

Authors:  D R Call; J A Nemzek; S J Ebong; G L Bolgos; D E Newcomb; D G Remick
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma.

Authors:  Douglas D Benson; Xianzhong Meng; David A Fullerton; Ernest E Moore; Joon H Lee; Lihua Ao; Christopher C Silliman; Carlton C Barnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-14       Impact factor: 3.619

6.  Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy.

Authors:  Minoru Kobayashi; Taro Kubo; Kenji Komatsu; Akira Fujisaki; Fumihito Terauchi; Shinsuke Natsui; Akinori Nukui; Shinsuke Kurokawa; Tatsuo Morita
Journal:  Med Oncol       Date:  2013-03-29       Impact factor: 3.064

7.  Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.

Authors:  Kentaro Iwanaga; Yanan Yang; Maria Gabriela Raso; Lijiang Ma; Amy E Hanna; Nishan Thilaganathan; Seyed Moghaddam; Christopher M Evans; Huaiguang Li; Wei-Wen Cai; Mitsuo Sato; John D Minna; Hong Wu; Chad J Creighton; Francesco J Demayo; Ignacio I Wistuba; Jonathan M Kurie
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

8.  Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

Authors:  Michael C Schmid; Judith A Varner
Journal:  J Oncol       Date:  2010-05-16       Impact factor: 4.375

9.  Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis.

Authors:  Julia Hobson; Phani Gummadidala; Brian Silverstrim; Dore Grier; Janice Bunn; Ted James; Mercedes Rincon
Journal:  Breast Cancer Res Treat       Date:  2013-05-29       Impact factor: 4.872

10.  Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.

Authors:  A McGarry Houghton; Danuta M Rzymkiewicz; Hongbin Ji; Alyssa D Gregory; Eduardo E Egea; Heather E Metz; Donna B Stolz; Stephanie R Land; Luiz A Marconcini; Corrine R Kliment; Kimberly M Jenkins; Keith A Beaulieu; Majd Mouded; Stuart J Frank; Kwok K Wong; Steven D Shapiro
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.